Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Twist Bioscience Corp
(NQ:
TWST
)
39.97
+0.42 (+1.06%)
Streaming Delayed Price
Updated: 1:22 PM EDT, Sep 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Twist Bioscience Corp
< Previous
1
2
3
4
5
6
7
8
9
Next >
Twist Bioscience to Present at Baird Global Healthcare Conference 2024
August 27, 2024
From
Twist Bioscience Corporation
Via
Business Wire
How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates
August 14, 2024
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:RXRX),(NASDAQ:EXAI),(NASDAQ:TWST),(NYSE:IQV) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Twist Bioscience Expands Gene Offering With Long Gene Fragments up to 5.0kb
August 08, 2024
From
Twist Bioscience Corporation
Via
Business Wire
How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates
August 14, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
August 06, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience and bitBiome Announce Strategic Collaboration and First Offering to Deliver One-of-a-Kind Enzymes for Biocatalysis
August 05, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Reports Fiscal Third Quarter 2024 Financial Results
August 02, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Announces Clinical Progression of Pure Biologics’ Antibody Candidate Discovered Using Twist’s Antibody Libraries
July 18, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Report Fiscal 2024 Third Quarter Financial Results on Friday, August 2, 2024
July 11, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Expands High-Throughput IgG Antibody Portfolio with Launch of CHO Express Antibodies
July 10, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Launches Synthetic RNA Control for H5N1 Influenza A
July 09, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Publishes Preclinical Data Detailing Discovery of Antibody Targeting Emerging Checkpoint Inhibitor
June 06, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Announces Participation in Department of Commerce Consortium Dedicated to AI Safety
June 04, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Present at Upcoming Investor Conferences
May 23, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening Applications
May 13, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
May 08, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results
May 02, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
April 18, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations
March 28, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing
March 05, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Present at Upcoming Investor Conferences
February 22, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
February 07, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience and Element Biosciences Collaborate on Exome Sequencing Solutions for AVITI System
February 06, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications
February 06, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Unveils Differentiated Ultra High-Throughput Library Preparation Solution at AGBT
February 05, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results
February 02, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Expands Express Genes Rapid Synthesis Service
January 24, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Report Fiscal 2024 First Quarter Financial Results on Friday, February 2, 2024
January 16, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Corporation Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
January 08, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Appoints Adam Laponis as Chief Financial Officer
January 05, 2024
From
Twist Bioscience Corporation
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.